Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Application for laboratory to join the UK Genetic Testing Network For help and clarification in completing this form please contact the UKGTN project team UKGTN Project team: UK Genetic Testing Network c/o National Specialised Commissioning Team 2nd Floor Southside 105 Victoria Street London SW1E 6QT e-mail: [email protected] Tel: 020 7932 3969 Fax: 020 7932 3800 Please refer to the ‘Process and Criteria for UKGTN Laboratory Membership as a Diagnostic or Technical Service Provider’ document before completing this application form. Please indicate the date of application Please indicate what type of UKGTN membership your laboratory is applying for a) Diagnostic membership b) Technical membership Laboratory details Laboratory name Laboratory Address Laboratory phone number Laboratory fax number Laboratory e-mail address Laboratory Web address Aug 2006 (revised Sept 2007, revised Oct 2009, revised Oct 2012) 1 Organisational details Head of Laboratory Tel Number Fax Number Email address Signature of Head of Laboratory Owning Institution Name and Address of Chief Executive of owning institution Signature of Chief Executive Please note that for NHS organisations, the UKGTN will inform the relevant NHS commissioners should the laboratory become a member. Aug 2006 (revised Sept 2007, revised Oct 2009, revised Oct 2012) 2 Criteria for participating laboratories Section 1 – to be completed by all applicants 1. Laboratory accreditation UKGTN requires laboratories to be either accredited by CPA or another recognised agency or to have lodged an application for accreditation. For those laboratories awaiting inspection accreditation should be achieved within 18 months, inspection schedule permitting. 1.1 Is the applicant Laboratory: a) Accredited by CPA for: Molecular genetic testing Cytogenetic testing Y/N Y/N CPA number: CPA number: b) Registered for accreditation with CPA Y/N (Accreditation should be achieved within 18 months of application to join UKGTN, inspection schedule permitting). Please state the specialties registered for: c) Accredited with another recognised agency of laboratory accreditation Y/N Please specify agency d) Registered for accreditation with another agency of laboratory accreditation Y/N (Accreditation should be achieved within 18 months of application to join UKGTN, inspection schedule permitting). Please specify agency e) For Technical members: Accredited with ISO 17025 Registered with the Care Quality Commission: Aug 2006 (revised Sept 2007, revised Oct 2009, revised Oct 2012) Y/N Y/N 3 Instructions for which sections and appendices to complete If your laboratory has full CPA accreditation for Cytogenetics or Molecular Genetics Section 2 (questions 2 to 6) Appendx 1 Notification of tests laboratory wishes to offer Appendix 2 Declaration of Interests If you are registered with CPA and awaiting inspection or registered with another recognised agency of laboratory accreditation please complete Section 3 (questions 8 to 17) Appendx 1 Notification of tests laboratory wishes to offer Appendix 2 Declaration of Interests Pages 5-8 Pages 9-17 If you are applying as a technical member accredited with ISO17025 and registered with the Care Quality Commission please complete Section 4 (questions 18 to 26 ) Appendx 1 Notification of tests laboratory wishes to offer Appendix 2 Declaration of Interests Aug 2006 (revised Sept 2007, revised Oct 2009, revised Oct 2012) Pages 18-23 4 Section 2 – to be completed by applicants with full CPA accreditation for Cytogenetics or Molecular Genetics 2. Reporting times Please complete the proforma in appendix 2, using a separate form for each test to be offered on the network (please make as many copies as required) stating: the levels of service offered (e.g. mutation screening /confirmation of known mutations/gene tracking/prenatal etc), reporting times for both urgent and non-urgent referrals and percentage compliance to the reporting times for the last full financial year prior to application. Please note tests offered to the network need to be available nationally. 3. Information on monitoring activity data There needs to be a minimum dataset for monitoring purposes, to include reporting times, number of tests per annum, geographic data on referrals (in the form of resident postcodes) to monitor equity of access and audit and outcome data to monitor effectiveness of service. Please indicate whether or not you return audit data to the relevant professional organisation when requested: CMGS Y/N ACC Y/N It is mandatory for the applicant laboratory to complete UKGTN audit/activity reviews as required. Activity data Service area: Cytogenetic Please give data for 1st April to 31st March of the most recent financial year listing the number of reports issued for each of the bands. See Appendix 3 for information on the Genetic Units System used to assign tests to bands. No of reports Band A – sample receipt and processing Band A – sample exports Band A – cell freezing/storage Band B Band C Band D Band E Service area: molecular Please give data for 1st April to 31st March of the most recent financial year listing the number of reports issued for each of the bands. See Appendix 3 for information on the Genetic Units System used to assign tests to bands. No of reports Band A – DNA extractions Band A – DNA exports Band B Band C Band D Not applicable Band E Band F Band G Band H Aug 2006 (revised Sept 2007, revised Oct 2009, revised Oct 2012) 5 The UKGTN will require the resident postcodes for laboratory reports issued Please estimate the current proportion of reports in which the resident postcode has been recorded. 4. Clinical environment The applicant laboratory needs to demonstrate that the lab has management arrangements and a critical mass capable of providing a supportive environment for a specialist service. This includes advice on clinical interpretation and reporting. Please describe what arrangements you have in place to access clinical advice to interpret the clinical significance of results and to make counselling services available to patients and their families. 5. Research and development activity The applicant laboratory should have a relationship with at least one University Department with expertise in genetics with an expectation that it would, through its University links, attract research grants and carry out research. 5.1 Please give details of University Department(s) or others with whom you have research links: Head of Department: Address of Department: 5.2 Please specify any tests that you have introduced into your laboratory in the past two years and advise which of these have been as a result of collaborations with a University department as listed in 5.1 Aug 2006 (revised Sept 2007, revised Oct 2009, revised Oct 2012) 6 5.3 Please specify any new techniques/technology that you have introduced into your laboratory in the past two years and advise which of these have been as a result of collaborations with a University department as listed in 5.1 5.4 Please list current research projects/collaborations and how they are funded. Current research projects/collaborations Description of how project/collaboration is funded 5.5 Please list the publications that your laboratory contributed to in the last financial year 6.Dissemination of information on availability of services In order to facilitate equal access to services, I agree that the applicant laboratory, as part of the UKGTN, will provide information to the UK Genetic Testing Network using standardised formats provided by them where applicable. I agree to inform the UKGTN of any changes to the laboratory services including changes in service provision, technology, organisational structures and appropriate research structures. I agree to the guidelines laid out in the document entitled ‘Framework for Delivering the UKGTN’ including the provision of requested information. Signed: Name (print): Position: Date: Aug 2006 (revised Sept 2007, revised Oct 2009, revised Oct 2012) 7 Section 3 – to be completed by applicants registered with CPA and awaiting inspection or registered with another recognised agency of laboratory accreditation please complete 7. Reporting times Please complete the proforma in appendix 2, using a separate form for each test to be offered on the network (please make as many copies as required) stating: the levels of service offered (e.g. mutation screening /confirmation of known mutations/gene tracking/prenatal etc), reporting times for both urgent and non-urgent referrals and percentage compliance to the reporting times for the last full financial year prior to application. Please note tests offered to the network need to be available nationally. 8. External Quality Assurance Evidence of participation in the relevant formal EQA schemes will be required by the UK Genetic Testing Network Laboratory Membership & Audit Working Group. 8.1List the external quality assurance Schemes in which you participate 8.2 Have you have been contacted by a Scheme Organiser with regard to persistent poor performance in the last 12 months? Y/N 9. Support from owning Institution and Host commissioners – for NHS organisations Applicant laboratories need to demonstrate the support from their owning institution to provide stability and quality of service including infrastructure, space and services. Arrangements for paying capital charges must be transparent and the host must indicate that this will lead to a planned and timely programme of capital (equipment) replacement. 9.1 How do you engage in the commissioning process? Please detail the frequency with which meetings are held with commissioners or purchasers Aug 2006 (revised Sept 2007, revised Oct 2009, revised Oct 2012) 8 9.2. What support do you receive from your owning institution with respect to infrastructure, space and service requirements and a timely programme of capital (equipment) replacement. Please detail the process by which the management of the owning institution and the laboratory interact e.g. type and frequency of meetings 9.3 Please specify the mechanism to replace obsolete items of equipment costing more than £10,000. 10. Information on monitoring activity data There needs to be a minimum dataset for monitoring purposes, to include reporting times, number of tests per annum, geographic data on referrals to monitor equity of access and audit and outcome data to monitor effectiveness of service. Please indicate whether or not you return audit data to the relevant professional organisation when requested: CMGS Y/N ACC Y/N It is mandatory for the applicant laboratory to complete UKGTN audit/activity reviews as required. Activity data Service area: Cytogenetic Please give data for 1st April to 31st March of the most recent financial year listing the number of reports issued for each of the bands. See Appendix 3 for information on the Genetic Units System used to assign tests to bands. No of reports Band A – sample receipt and processing Band A – sample exports Band A – cell freezing/storage Band B Band C Band D Band E Service area: molecular Please give data for 1st April to 31st March of the most recent financial year listing the number of reports issued for each of the bands. See Appendix 3 for information on the Genetic Units System used to assign tests to bands. Aug 2006 (revised Sept 2007, revised Oct 2009, revised Oct 2012) 9 No of reports Band A – DNA extractions Band A – DNA exports Band B Band C Band D Band E Band F Band G Band H Not applicable 10.1 The UKGTN will require the resident postcodes for laboratory reports issued Please estimate the current proportion of reports in which the resident postcode has been recorded. 11. Provision of a robust and sustainable service The applicant laboratory needs to demonstrate that it can provide a reliable service. Considerations include staffing (vacancies, maternity/long and short term sick leave, holidays and training), technical considerations (planning for technical failure) and contingency plans for major incidents. 11.1 For NHS organisations Staffing (Please give details as at April 1st of the year of application) Please provide staffing structure and indicate the Agenda for Change band for each position and whether or not the current post holder is HPC registered. 11.2 For non-NHS organisations Please provide staffing structure for laboratory and indicate whether the current post holder for each position is HPC registered. 11.3 Describe how you deal with vacancies, maternity/long and short term sick leave, holidays and training Aug 2006 (revised Sept 2007, revised Oct 2009, revised Oct 2012) 10 11.4 Describe how you plan for technical failure and major incidents 11.5 What facility do you have for the long-term storage of samples? 11.6 What is your policy for long term storage of samples? 12. Clinical, technical and scientific environment The applicant laboratory needs to demonstrate that the lab has management arrangements and a critical mass capable of providing a supportive environment for a specialist service. This includes support for technical trouble shooting, advice on clinical interpretation and reporting and a scientific and management objective setting environment capable of absorbing and integrating new scientific and technical developments relevant to the specialist service. Clinical 12.1 Please describe what arrangements you have in place to access clinical advice to interpret the clinical significance of results and to make counselling services available to patients and their families. Aug 2006 (revised Sept 2007, revised Oct 2009, revised Oct 2012) 11 Technical 12.2 Please describe the support you have in place to deal with technical trouble shooting Scientific environment 12.3 Please provide information on the scientific and management arrangements you have in place to allow for the integration of new scientific and technical developments into your service. 13. Audit The applicant laboratory needs to demonstrate a commitment and ability to carry out clinical audit relevant to the specialist test. Please provide details of clinical audit activity that you have undertaken during 1st April to 31st March of the most recent financial year. 14. Research and development activity The applicant laboratory should have a relationship with at least one University Department with expertise in genetics with an expectation that it would, through its University links, attract research grants and carry out research. 14.1 Please give details of University Department(s) or others with whom you have formal links: Head of Department: Address of Department: Aug 2006 (revised Sept 2007, revised Oct 2009, revised Oct 2012) 12 14.2 Please specify any tests that you have introduced into your laboratory in the past two years and advise which of these have been as a result of collaborations with a University department as listed in 15.1 14.3 Please specify any new techniques/technology that you have introduced into your laboratory in the past two years and advise which of these have been as a result of collaborations with a University department as listed in 15.1 14.4 Please list current research projects/collaborations and how they are funded. Current research projects/collaborations Description of how project/collaboration is funded Aug 2006 (revised Sept 2007, revised Oct 2009, revised Oct 2012) 13 14.5 Please list the publications that your laboratory contributed to in the last financial year 15.Responsibility of service 15.1 Please identify the chain of responsibility for any errors: 15.2 Please demonstrate compliance to legal imperatives and the need for indemnification, which includes compliance with the ‘In vitro diagnostic medical devices directive 98/79/EC’ and the Human Tissue Act licensing arrangements 15.3 Please identify the lines of responsibility for subcontracting and provide information on any arrangements that are in place for sub-contracting to another provider: Aug 2006 (revised Sept 2007, revised Oct 2009, revised Oct 2012) 14 16. Dissemination of information on availability of services In order to facilitate equal access to services, I agree that the applicant laboratory, as part of the UKGTN, will provide information to the UK Genetic Testing Network using standardised formats provided by them where applicable. I agree to inform the UKGTN of any changes to the laboratory services including changes in service provision, technology, organisational structures and appropriate research structures. I agree to the guidelines laid out in the document entitled ‘Framework for Delivering the UKGTN’ including the provision of requested information. Signed: Name (print): Position: Date: Aug 2006 (revised Sept 2007, revised Oct 2009, revised Oct 2012) 15 Section 4 – to be completed by applicants accredited to ISO17025 & registered with the CQC Technical providers 17. Reporting times Please complete the proforma in appendix 2, using a separate form for each test to be offered on the network (please make as many copies as required) stating: the levels of service offered (e.g. mutation screening /confirmation of known mutations/gene tracking/prenatal etc), reporting times for both urgent and non-urgent referrals and percentage compliance to the reporting times for the last full financial year prior to application. Please note tests offered to the network need to be available nationally. 18. External Quality Assurance Evidence of participation in the relevant formal EQA schemes will be required by the UK Genetic Testing Network Laboratory Membership & Audit Working Group. 18.1List the external quality assurance Schemes in which you participate 18.2 Have you have been contacted by a Scheme Organiser with regard to persistent poor performance in the last 12 months? Y/N 19. Support from owning Institution Applicant laboratories need to demonstrate the support from their owning institution to provide stability and quality of service including infrastructure, space and services. Arrangements for paying capital charges must be transparent and the host must indicate that this will lead to a planned and timely programme of capital (equipment) replacement. What support do you receive from your owning institution with respect to infrastructure, space and service requirements and a timely programme of capital (equipment) replacement. Please detail the process by which the management of the owning institution and the laboratory interact e.g. type and frequency of meetings Aug 2006 (revised Sept 2007, revised Oct 2009, revised Oct 2012) 16 20.Provision of a robust and sustainable service The applicant laboratory needs to demonstrate that it can provide a reliable service. Considerations include staffing (vacancies, maternity/long and short term sick leave, holidays and training), technical considerations (planning for technical failure) and contingency plans for major incidents. 20.1 For NHS organisations Staffing (Please give details as at April 1st of the year of application) Please provide staffing structure and indicate the Agenda for Change band for each position and whether or not the current post holder is HPC registered. 20.2 For non-NHS organisations Please provide staffing structure for laboratory and indicate whether the current post holder for each position is HPC registered. 20.3 Describe how you deal with vacancies, maternity/long and short term sick leave, holidays and training 20.4 Describe how you plan for technical failure and major incidents 20.5 What facility do you have for the long-term storage of samples? 20.6 What is your policy for long term storage of samples? Aug 2006 (revised Sept 2007, revised Oct 2009, revised Oct 2012) 17 21. Technical and scientific environment The applicant laboratory needs to demonstrate that the lab has management arrangements and a critical mass capable of providing a supportive environment for a specialist service. This includes support for technical trouble shooting and a scientific and management objective setting environment capable of absorbing and integrating new scientific and technical developments. Technical 21.1 Please describe the support you have in place to deal with technical trouble shooting Scientific environment 21.2 Please provide information on the scientific and management arrangements you have in place to allow for the integration of new scientific and technical developments into your service. 23. Research and development activity It is recommended that the applicant laboratory should have a formal relationship with at least one University Department with expertise in genetics although it is recognised that this is not a requirement for TSPs. 23.1 Please give details of University Department(s) or others with whom you have formal links: Head of Department: Address of Department: Aug 2006 (revised Sept 2007, revised Oct 2009, revised Oct 2012) 18 23.2 Please specify any tests that you have introduced into your laboratory in the past two years and advise which of these have been as a result of collaborations with a University department as listed in 24.1 23.3 Please specify any new techniques/technology that you have introduced into your laboratory in the past two years and advise which of these have been as a result of collaborations with a University department as listed in 24.1 23.4 Please list current research projects/collaborations and how they are funded. Current research projects/collaborations Description of how project/collaboration is funded 23.5 Please list the publications that your laboratory contributed to in the last financial year Aug 2006 (revised Sept 2007, revised Oct 2009, revised Oct 2012) 19 24. Responsibility of service 24.1 Please identify the chain of responsibility for any errors: 24.2 Please demonstrate compliance to legal imperatives and the need for indemnification, which includes compliance with the 'In vitro diagnostic medical devices directive 98/79/EC' and the Human Tissue Act licensing arrangements 24.3 Please identify the lines of responsibility for subcontracting and provide information on any arrangements that are in place for sub-contracting to another provider: 25. Services to be provided to UKGTN Diagnostic Laboratories Technical Service Providers are required to provide services to UKGTN Diagnostic Laboratories in order to maintain membership of UKGTN. 25.1 Using appendix 1 (please make as many copies as required), please provide a list of the services that will be available to UKGTN Diagnostic Laboratories. 25.2 If services are already being provided to UKGTN Diagnostic Laboratories, please list the laboratory name and the services that are being provided. Aug 2006 (revised Sept 2007, revised Oct 2009, revised Oct 2012) 20 26. Dissemination of information on availability of services In order to facilitate equal access to services, I agree that the applicant laboratory, as part of the UKGTN, will provide information to the UK Genetic Testing Network using standardised formats provided by them where applicable. I agree to inform the UKGTN of any changes to the laboratory services including changes in service provision, technology, organisational structures and appropriate research structures. I agree to the guidelines laid out in the document entitled ‘Framework for Delivering the UK GTN’ including the provision of requested information. Signed: Name (print): Position: Date: Aug 2006 (revised Sept 2007, revised Oct 2009, revised Oct 2012) 21 Appendix 1: Proforma for the notification of tests that the laboratory would like to offer to UKGTN. Laboratories applying for diagnostic membership will be required to submit Gene Dossiers (or additional provider forms where the test is already on the Directory) for tests that they wish to provide to the UKGTN once their application for membership has been accepted to pass stage 1. UKGTN tests must be provided as a national service. UKGTN Website information proforma – must be completed Please indicate what service you propose to offer. This is the information that will be displayed on the application is successful Name of disease/ OMIM number(s) condition Name of gene(s) OMIM number(s) Service levels Qualifiers Turnaround time (Working days) & % compliance Sequencing of the entire coding region of a gene UKGTN website if your Price (£) - Please state whether price is per gene or for all genes Prenatal Diagnosis Postnatal Diagnosis Routine Postnatal Diagnosis Urgent Sequencing of the entire coding region of a gene PLUS copy number analysis Prenatal Diagnosis Sequencing of selected exons Prenatal Diagnosis Postnatal Diagnosis Routine Postnatal Diagnosis Urgent Postnatal Diagnosis Routine Postnatal Diagnosis Urgent Mutation Scanning Prenatal Diagnosis Postnatal Diagnosis Routine Postnatal Diagnosis Urgent Targeted mutation analysis Prenatal Diagnosis Postnatal Diagnosis Routine Postnatal Diagnosis Urgent Testing for known mutations in family members Prenatal Diagnosis Postnatal Diagnosis Routine Postnatal Diagnosis Urgent Gene Tracking Prenatal Diagnosis Postnatal Diagnosis Routine Postnatal Diagnosis Urgent Targeted copy number analysis Prenatal Diagnosis Postnatal Diagnosis Routine Postnatal Diagnosis Urgent Whole genome analysis for copy number imbalance Prenatal Diagnosis Postnatal Diagnosis Routine Postnatal Diagnosis Urgent Chromosome analysis for balanced structural chromosome rearrangements Prenatal Diagnosis Chromosome instability (breakage) analysis Prenatal Diagnosis Postnatal Diagnosis Routine Postnatal Diagnosis Urgent Postnatal Diagnosis Routine Postnatal Diagnosis Urgent Please state any QA schemes that you undertake for this disease/condition Aug 2006 (revised Sept 2007, revised Oct 2009, revised Oct 2012) 22 Appendix 2 DECLARATION OF INTEREST To be completed by Directors/senior staff of the organisation responsible for the laboratory I ..........................................................……………………………. wish to declare that I currently have/do not have* interests which are material and relevant to the UKGTN service or any NHS organisations. *please delete as appropriate Interests which are relevant and material are: 1. Directorships, including non-executive Directorships, held in private companies or PLCs (with the exception of those of dormant companies) 2. Ownership or part ownership of private companies, businesses or consultancies likely or possibly seeking to do business with the NHS 3. Majority or controlling shareholdings in organisations likely or possibly seeking to do business with the NHS 4. A position of trust in a charity or voluntary organisation in the field of health and social care 5. Any other connection with a voluntary or other organisation contracting for NHS services My interests are listed below: Please state ‘nil’ if no interests are to be declared (Please note that the interest of members spouses or cohabiting partners should also be regarded as relevant) Signed ................................................ Date ................................................... Please sign, date and return with your application form to UKGTN Team c/o National Specialised Commissioning Team, 2nd Floor, Southside, 105 Victoria Street, London , SW1E 6QT Aug 2006 (revised Sept 2007, revised Oct 2009, revised Oct 2012) 23 Appendix 3 Genetic Units (GenUs) system to record laboratory activity Yellow refers to molecular genetics Blue refers to cytogenetics Band A GenU Score 1 General examples All DNA extractions to include o extract > test locally o extract > DNA banking All RNA extraction Sample receipt, booking in, and processing of blood sample, haematological blood/bone marrow sample, PET samples. Covers: o Sample preparation, setting up of culture(s) and processing of sample to provide a cell suspension for cytogenetic analyses, processing of PET samples for FISH and/or o DNA extraction and banking for molecular studies DNA/sample/cell culture export (added to be consistent with molecular) DNA/cell culture sample export Cell freezing/storage Single amplicon (genotyping or sequencing) A B 1 2 Specific examples Aug 2006 (revised Sept 2007, revised Oct 2009, revised Oct 2012) 24 Samples processed for both Cytogenetic and Molecular Genetic Studies are considered as separate. Interpretation/undertaking segregation of results from another laboratory Re-issue of report for sample previously tested (repeat request for same test). Freezing/storage – this is a one-off charge for potentially long-term storage FraX PCR Haemochromatosis Factor V Jak2 HD (diagnostic and predictive tests) Other triplet disorders where a single PCR is required (eg SBMA) Y deletions FLT3 NPM1 Band GenU Score General examples C 4 D E 7 10 Specific examples Sample receipt, booking in, and processing of amniotic fluid sample, CV sample, solid tissue sample, lymph node, tumour sample. Covers: o sample preparation, setting up of culture(s) and processing of sample to provide a cell suspension for cytogenetic analyses Embryo preparation of PGD analysis Genotyping 2-4 amplicons Sequencing: Very small gene with 2-4 exons/amplicons Sequencing: Predictive tests, confirmations and carrier tests MS-PCR MLPA with no other test (including DMD) Prenatal tests to include the MCC 1 lane on Southern Triplet disorders that require two PCRs (allele specific and TP-PCR) Aneuploidy (to include 13, 18, 21 and X/Y) Identity/paternity tests Direct CVS analysis Rapid aneuploidy testing for +13, +18 and +21, X/Y (QF-PCR FISH) Simple FISH test defined as a single interpretative event using commercial probe/kit Kit based MLPA Targeted array CGH follow up studies Blood, Amniotic fluid, CVS culture, or Solid Tissue G-band constitutional analysis Haematological (marrow, blood, lymph node, effusion) or tumour G-band analysis 5-19 amplicons (MLPA to count as 2 amplicons when part of full screen) All linkage tests including UPD Array CGH (whole genome analysis) Chromosome breakage studies, eg FA, or AT Combined FISH analysis of probes that must be applied and interpreted Aug 2006 (revised Sept 2007, revised Oct 2009, revised Oct 2012) 25 CF-ARMS, CF-OLA, CF-HT AS/PWS FraX if Southern blotted DM, Friedreich’s ataxia RT PCR BCR/ABL-1 Includes slide making/banding an FISH preparation Microdeletion testing Break apart probes Fusion probes (includes BCR/ABL) Post bone marrow transplant XY donor scoring Targeted array CGH follow up can be by FISH or aCGH Includes slide making and G-banding G-band analysis appropriate to referral reason and if necessary other conventional staining (eg C band, NOR) to aid interpretation. Sequencing MECP2 DMD linkage AS/PWS if linked markers used Includes processing steps post DNA extraction. Includes SCE prep and analysis for FA, and scanning for chromosome 7 and 14 Band GenU Score General examples Specific examples together to provide a single diagnostic/prognostic report F G 15 25 20-49 amplicons (MLPA to count as 2 amplicons when part of full screen) 50-100 amplicons (MLPA to count as 2 amplicons when part of full screen) H 40 Over 100 amplicons Aug 2006 (revised Sept 2007, revised Oct 2009, revised Oct 2012) 26 rearrangements for AT. FISH panels typically 2-4 probes eg CLL FISH panel; most NHL FISH panels; MLL, BCR-ABL & ETV6-RUNX1 applied to a presentation ALL; myeloma FISH panel limited to clinically relevant abnormalities Sequencing factor 8 Sequencing FBN1 Sequencing BRCA1+BRCA2 Sequencing a group of genes in parallel that contribute to a single report